Chas­ing the next wave of obe­si­ty drugs, Met­sera files for an IPO

Met­sera has filed to go pub­lic less than a year af­ter its launch, cap­i­tal­iz­ing on the fer­vent in­vestor in­ter­est — and in­tense com­pe­ti­tion — for all things …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER